High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$694K
$694,561
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $29,094 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $20,481 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $70,027 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $20,829 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $73,294 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $51,646 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $6,689 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-19 | $120,000 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-04 | $112,500 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-14 | $130,000 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-11 | $60,000 | S | Form 4 |